< to news overview

Innovative Medicines Initiative has now launched IMI2 – Call 13


Innovative Medicines Initiative launches new Calls for proposals


The Innovative Medicines Initiative has now launched IMI2 – Call 13 with the following topics:

  • Assessment of the uniqueness of diabetic cardiomyopathy relative to other forms of heart failure using unbiased pheno-mapping approaches
  • Genome-environment interactions in inflammatory skin disease
  • The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use
  • Mitochondrial dysfunction in neurodegeneration
  • Support and coordination action for the projects in the neurodegeneration area of the Innovative Medicines Initiative
  • A sustainable European induced pluripotent stem cell platform
  • Linking digital assessment of mobility to clinical endpoints to support regulatory acceptance and clinical practice
  • Human tumour microenvironment immunoprofiling
  • ConcePTION – Continuum of evidence from pregnancy exposures, reproductive toxicology and breastfeeding to improve outcomes now
  • Improving the preclinical prediction of adverse effects of pharmaceuticals on the nervous system
  • Translational safety biomarker pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease
  • Pilot programme on a clinical compound bank for repurposing – this programme contains four topics on cardiovascular diseases and diabetes; respiratory diseases; neurodegenerative diseases; and rare/orphan diseases

Deadline for submitting short proposals: 28 February 2018

Find out more

All topic texts, Call documentation and details of how to apply can be found on the IMI website – www.imi.europa.eu

Webinars

Registration is open for the webinars on IMI2 – Call 13, which run until 15 December. We are running webinars on all Call topics, as well as a webinar on IMI’s rules and procedures. In addition, this time we will have a dedicated webinar for small and medium-sized enterprises (SMEs).

Tips on finding partners and preparing your proposal

The IMI website includes pages with advice for applicants and guidance on how to find project partners.

Why apply?

IMI Calls for proposals represent an excellent opportunity for researchers to take part in ground-breaking collaborative projects that aim to deliver tangible benefits for patients. Scientists from academia, industry, SMEs, mid-sized companies, hospitals and patients’ organisations are encouraged to get involved in our projects. Our success stories page offers a glimpse of the kinds of things IMI projects can achieve, and includes testimonials from project participants.

Questions? E-mail infodesk@imi.europa.eu or contact Immuno Valley!